OrfoNeuro ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
Estimate generation in progress, please wait...
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  19.7% 15.6% 12.0% 14.2% 17.5%  
Credit score (0-100)  7 12 18 15 8  
Credit rating  B BB BB BB B  
Credit limit (kDKK)  -0.0 -0.0 -0.0 -0.0 -0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  -146 -155 -79.3 -90.2 -148  
EBITDA  -146 -155 -79.3 -90.2 -148  
EBIT  -146 -155 -79.3 -90.2 -148  
Pre-tax profit (PTP)  -159.7 -168.5 -95.5 -108.8 -178.5  
Net earnings  -140.3 -152.9 -88.3 -95.0 -208.1  
Pre-tax profit without non-rec. items  -160 -168 -95.5 -109 -179  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  -263 -416 -504 -599 -808  
Interest-bearing liabilities  0.0 0.0 0.0 0.0 159  
Balance sheet total (assets)  152 51.7 46.1 53.0 47.1  

Net Debt  -117 -7.7 -9.8 -0.2 157  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  -146 -155 -79.3 -90.2 -148  
Gross profit growth  28.4% -6.3% 48.8% -13.7% -63.7%  
Employees  0 0 0 0 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  152 52 46 53 47  
Balance sheet change%  -5.8% -65.9% -10.8% 14.9% -11.0%  
Added value  -145.9 -155.0 -79.3 -90.2 -147.7  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  -4.0 -5.0 -5.0 -5.0 -5.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  100.0% 100.0% 100.0% 100.0% 100.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  -41.7% -35.1% -15.6% -15.0% -19.6%  
ROI %  -43.9% -36.5% -16.1% -33.5% -185.9%  
ROE %  -89.7% -150.3% -180.6% -191.8% -415.8%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  -63.4% -88.9% -91.6% -91.9% -94.5%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  80.1% 5.0% 12.3% 0.3% -106.5%  
Gearing %  0.0% 0.0% 0.0% 0.0% -19.7%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 0.0% 38.8%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  13.1 2.5 3.0 3.6 1.3  
Current Ratio  13.1 2.5 3.0 3.6 1.3  
Cash and cash equivalent  116.9 7.7 9.8 0.2 1.6  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  140.3 30.8 23.1 29.6 8.8  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0